The history of ergot of rye (Claviceps purpurea) III: 1940

Abstract

The period 1940–80 in the history of ergot was dominated by two investigators, Arthur Stoll and Albert Hofmann. There was great excitement when their group isolated from ergot preparations the powerful psychotropic agent lysergic acid diethylamide (LSD). It was thought that this substance would help to find the cause of schizophrenia and other psychotic disorders, but it would prove to be a great disappointment and Hofmann would say later, in private, that he regretted having spent so much time on the compound. By contrast, bromocriptine, derived from ergocriptine, would prove a pivotal substance in our knowledge of dopamine receptors in the central nervous system. It is widely used for the suppression of lactation, the treatment of prolactinomas and the management of Parkinson’s disease.

Keywords

Bromocriptine dopamine receptors ergot Albert Hofmann lysergic acid diethylamide psychosis

Get full access to this article

View all access options for this article.

References

1 Holmstedt

Liljestrand

, editors. Readings in pharmacology. New York: Raven Press; 1981. p. 209–13.

Hofmann

Ergot – a rich source of pharmacologically active substances. In: Swain T, editor. Plants in the development of modern medicine. Cambridge, MA:: Harvard University Press; 1972. p. 236–60.

Lee

MR.

The history of ergot II: 1900–40. J R Coll Physicians Edinb 2009; 39:365–9.

4 Stoll

Hofmann

[Partial synthesis of alkaloids of the ergonovine type.] Helv Chim Acta 1943; 26:944–65. In German. doi:10.1002/hlca.19430260326

Hofmann

LSD: my problem child. New York: McGraw Hill; 1980.

Stoll

WA.

[Lysergic acid diethylamide, a hallucinogen from the ergot group.] Schweiz Arch Neut 1947; 60:279. In German.

7See http://www.erowid.org/references/refs.php for a complete list of LSD research papers.

Smart

Bateman

Unfavourable reactions to LSD: a review and analysis of the available case reports. Can Med Assoc J 1967; 97:1214–21.

Cohen

A classification of LSD complications. Psychosomatics 1966; 7:182–6.

10.

10Obituary: Albert Hofmann. Daily Telegraph; 20 May 2008. Available from: http://www.telegraph.co.uk/news/obituaries/1912485/Obituary-Albert-Hofmann-LSD-inventor.html

11.

11 Hofmann

Tscherter

[Isolation of lysergic acid alkaloids from the Mexican drug ololiuqui (Rivea corymbosa (L.) Hall.f.).] Experientia 1960;16:414. In German. doi:10.1007/BF02178840

12.

12 Stauffacher

Tscherter

Hofmann

[Isolation of ergosine and ergosinine as well as agroclavine from seeds of Ipomoea argyrophylla Vatke (Convolvulaceae). 64. On ergot alkaloids (1)] Helv Chim Acta 1965; 48:1379–80. In German. doi:10.1002/hlca.19650480618

13.

Shelesnyak

MC.

Ergotoxine inhibition of deciduoma formation and its reversal by progesterone. Am J Physiol 1954; 179:301–4.

14.

Flückiger

The pharmacology of bromocriptine. In: Bayliss RIS, Turner P, Maclay WP, editors. Pharmacological and clinical aspects of bromocriptine (Parlodel). Tunbridge Wells: MCS Consultants; 1976. p. 12–26.

15.

Giacomini

GA.

Traité philosophique et expérimental de matière médicale et de thérapeutique. Paris: Bureau de l’encyclopédie; 1839.

16.

16 Joint Formulary Committee. British National Formulary. 57 ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2008. p. 410–2.

The history of ergot of rye (Claviceps purpurea) III: 1940–80

Abstract

Keywords

Get full access to this article

References